News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ranbaxy Pharmaceuticals Inc. Launches Authorized Generic Version of Caduet® In the U.S.


12/6/2011 7:02:34 AM

PRINCETON, N.J. & GURGAON, India--(BUSINESS WIRE)--Ranbaxy Pharmaceuticals Inc., a wholly owned subsidiary of Ranbaxy Laboratories Ltd. (RLL, NSE: RANBAXY, BSE: 500359) (“Ranbaxy”), has launched an authorized generic version of Caduet® in the U.S. market, as part of an agreement with Pfizer Inc.

Read at BioSpace.com


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES